NYSEARCA:LDRSInnovator IBD ETF Leaders ETF Stock Price, Forecast & News

Innovator IBD ETF Leaders ETF's stock was trading at $19.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LDRS shares have increased by 11.3% and is now trading at $21.84. View which stocks have been most impacted by Coronavirus.

Innovator IBD ETF Leaders ETF declared a quarterly dividend on Monday, December 30th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.1333 per share on Thursday, January 2nd. This represents a $0.53 annualized dividend and a yield of 2.44%. The ex-dividend date is Monday, December 30th. View Innovator IBD ETF Leaders ETF's dividend history.

Media coverage about LDRS stock has trended very negative on Monday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innovator IBD ETF Leaders ETF earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Innovator IBD ETF Leaders ETF.

Innovator IBD ETF Leaders ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LDRS."

Shares of LDRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LDRS stock can currently be purchased for approximately $21.84.

Innovator IBD ETF Leaders ETF has a market capitalization of $8.74 million.